EndoSec (Application Security Automation) Dossier

Operating within the technology and specialized security software sector, EndoSec (Application Security Automation) generated an estimated annual revenue of $941,105. EndoSec (Application Security Automation) achieved these financial results primarily through the development and licensing of cryptographic IP cores, specialized engineering services encompassing anti-tamper planning, and a strategic Business-to-Government reseller model.

Financial Highlights

* Estimated Annual Revenue: $941,105

* Total Employee Count: 11

* Year Established: 2013

* Headquarters Location: Washington, DC

* Primary Revenue Geography: United States

* Target Market Concentration: United States government agencies, Department of Defense, and aerospace prime contractors

* Key Distribution Channels: Direct operations spanning offices in Washington DC, Virginia, Indiana, and North Carolina

EndoSec (Application Security Automation) operates a highly specialized distribution model tailored for strict regulatory compliance requirements within the defense sector. To secure its niche market position and mitigate client concentration risks associated with heavy reliance on government budgets, EndoSec (Application Security Automation) functions as the... Sign in / Sign up to learn more about EndoSec LLC

Continue your research by chatting with our AI financial analyst about EndoSec LLC. Ask follow-up questions, request specific analysis, or explore investment scenarios. All insights are grounded in verified financial data and SEC filings.

Start your analysis with these investor-focused questions:

• EndoSec relies heavily on the US Government and DoD for its revenue base. How does EndoSec plan to manage its high client concentration risk, and what strategic initiatives in FY2025 could leverage its commercial partnerships with Keysight and Intrinsic ID to diversify its revenue streams?
• Given EndoSec's status as a Veteran-Owned Small Business with a workforce of 100% cleared US citizens, how does the company translate these operational advantages into a competitive moat against larger, established aerospace and defense contractors?
• EndoSec is actively developing Post-Quantum cryptographic algorithms like ML-KEM and ML-DSA. How does this innovation pipeline position EndoSec's product portfolio against rapid technological shifts, and what is the anticipated impact on its FY2025 licensing revenues?
• With an estimated annual revenue of approximately $941,000 and a lean team of 11 employees, what are the primary scalability constraints for EndoSec's anti-tamper engineering services and IP licensing model heading into FY2025?
• EndoSec operates an exclusive B2G reseller model for Keysight and Intrinsic ID products. How does this reseller segment complement EndoSec's proprietary hardware security and PUF technologies in terms of overall margin profile and market penetration strategy?